Curanex Pharmaceuticals closes IPO of 3.75M shares at $4.00, raising $15M gross

Curanex Pharmaceuticals Inc

Gross proceeds of $15M from IPO of 3,750,000 shares at $4.00 per share on firm commitment basis.
Net proceeds approximately $12.1M after underwriting discounts and estimated offering expenses.
Common stock began trading on Nasdaq Capital Market on Aug 26, 2025 under ticker CURX.
Underwriters granted 45-day option to purchase up to 562,500 additional shares at $4.00 per share.
Lead underwriter Dominari Securities LLC; co-underwriters Pacific Century Securities LLC and Revere Securities LLC.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.